Featured Content

Hospitalization Rates Higher in Survivors of Adolescent Cancer

Those diagnosed with cancer during adolescence or young adulthood are at increased risk for hospitalization compared to those who did not have cancer.

Cost of Cancer Care Addressed at AACR Meeting

Financial stress of cancer care as well as factors that make certain populations more susceptible to certain types of cancers were key points.

HER2 Subtype More Responsive to Single, Dual Regimens

A phase 3 trial revealed that the HER2-enriched molecular subtype of breast cancer is more responsive to both dual and single targeting regimens.

Antiobiotic Resistance Puts Patients at Increased Risk

Increasing resistance to standard prophylactic antibiotics poses a serious and growing danger for patients undergoing immunosuppressing cancer chemotherapies.

Breast Cancer Q&A With Charles Vogel, MD

Dr. Charles Vogel, a medical oncologist, answers Cancer Therapy Advisor's questions on past and future advances in breast cancer care.

Breast Cancer Resources

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs